| 232.79 5.23 (2.3%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 276.18 | 1-year : | 322.58 |
| Resists | First : | 236.46 | Second : | 276.18 |
| Pivot price | 224.49  |
|||
| Supports | First : | 220.94 | Second : | 211.36 |
| MAs | MA(5) : | 230.5 |
MA(20) : | 223.06 |
| MA(100) : | 220.57  |
MA(250) : | 219.82 |
|
| MACD | MACD : | 2.8 |
Signal : | 1.5 |
| %K %D | K(14,3) : | 79.6 |
D(3) : | 83.3 |
| RSI | RSI(14): 62.5 |
|||
| 52-week | High : | 254 | Low : | 195.47 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ STE ] has closed below upper band by 14.9%. Bollinger Bands are 21.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 234.93 - 235.86 | 235.86 - 236.67 |
| Low: | 224.47 - 225.61 | 225.61 - 226.59 |
| Close: | 230.8 - 232.68 | 232.68 - 234.3 |
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Fri, 26 Jul 2024
This Is Why We Think STERIS plc's (NYSE:STE) CEO Might Get A Pay Rise Approved By Shareholders - Yahoo Finance
Thu, 25 Jul 2024
Steris PLC stock underperforms Thursday when compared to competitors - MarketWatch
Tue, 23 Jul 2024
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
Tue, 23 Jul 2024
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024 - StockTitan
Tue, 23 Jul 2024
Intech Investment Management LLC Sells 3,784 Shares of STERIS plc (NYSE:STE) - Defense World
Tue, 23 Jul 2024
Mitsubishi UFJ Trust & Banking Corp Sells 3,384 Shares of STERIS plc (NYSE:STE) - Defense World
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 99 (M) |
| Shares Float | 99 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 98.8 (%) |
| Shares Short | 2,960 (K) |
| Shares Short P.Month | 2,930 (K) |
| EPS | 5.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 63.72 |
| Profit Margin | 7.3 % |
| Operating Margin | 18.8 % |
| Return on Assets (ttm) | 5.1 % |
| Return on Equity (ttm) | 8.9 % |
| Qtrly Rev. Growth | 2.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 51.99 |
| EBITDA (p.s.) | 13.75 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 973 (M) |
| Levered Free Cash Flow | -195 (M) |
| PE Ratio | 42.01 |
| PEG Ratio | 2.4 |
| Price to Book value | 3.65 |
| Price to Sales | 4.47 |
| Price to Cash Flow | 23.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|